EuroPCR 2026
4 stories
-
healthThe Debate Over Treating High-Risk Heart Plaques
Experts at EuroPCR 2026 debate identifying and treating vulnerable coronary plaque, which may cause future heart attacks despite normal blood flow tests.
-
healthTTVI Adoption Surges in Germany, Outperforming Surgery for Tricuspid Regurgitation
A German nationwide study presented at EuroPCR 2026 shows transcatheter tricuspid valve interventions (TTVI) dramatically increased from 2018-2023, with lower mortality and shorter hospital stays compared to surgery.
-
healthEuroPCR 2026: Prioritizing Complications and Hands-On Learning
Course director Thomas Cuisset outlines EuroPCR 2026's focus on complications, novel CTO and calcium labs, and evolving PCI-TAVI strategies.
-
healthAI Boosts Confidence for OCT-Guided Heart Procedures at EuroPCR 2026
New research shows AI assistance significantly improves clinician confidence in OCT-guided PCI decisions, especially for less experienced doctors.